Epidemiology of cancer in Chile and worldwide: Present and future;Cancer en Chile y el mundo: Una mirada epidemiologica, presente y futuro

Revista Medica Clinica Las Condes

Volumn 24, Issue 4, 2013, Pages 531-552

  Laura Itriago, G ^a   Nicolas Silva, I ^b   Giovanna Cortes, F ^a  

^a CLÍNICA LAS CONDES   (Chile)

^b UNIVERSITY OF CHILE   (Chile)

Author keywords

Cancer; epidemiology; global burden

Indexed keywords

EID: 85148900712     PISSN: 07168640     EISSN: 25310186     Source Type: Journal    
DOI: 10.1016/S0716-8640(13)70195-0     Document Type: Article

References (54)

1. World Health Organization. Causes of death. WHO. The global burden of disease, 2004, WHO Press, Geneva, 8–26.
2. Mathers, C.D., Loncar, D., Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med, 3(11), 2006, e442 doi:10.1371/ journal.pmed.0030442.
3. World Bank. Overview. World Bank. World Development Report: Investing in Health, 1993, Oxford University Press, New York, 1–16.
4. Christopher, J., Theo, Vos, Rafael, L., et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. The Lancet 380 (2012), 2197–2223.
5. United Nations. Human Development Index. Available at: http://hdr.undp.org/en/statistics/hdi/ Last accessed: 15, March, 2013.
6. Soerjomataram, I., Lortet-Tieulent, J., Parkin, D.M., et al. Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions. The Lancet 380 (2012), 1840–1850.
7. Ministerio de Salud. Informe final: Estudio de carga enfermedad y carga atribuible. 2008.
8. Marshall, S., Bulletin of the World Health Organization, 82(7), 2004.
9. American Cancer Society. Global Cancer Facts and Figures 2008; 2nd edition:1-60.
10. Bray, F., et al. Predicting the future burden of cáncer. Nat.Rev.cancer 6 (2006), 63–74.
11. Bosetti, C., Malvezzi, M., Chatenoud, L., et al. Trends in cancer mortality in the Americas, 1970-2000. Ann Oncol 16 (2005), 489–511.
12. Edwards, B.K., Ward, E., Kohler, B.A., et al. Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer 116 (2010), 544–573.
13. Ezzati, M., Henley, S.J., Lopez, A.D., Thun, M.J., Role of smoking in global and regional can- car epidemiology: current patterns and data needs. Int J Cancer 116 (2005), 963–971.
14. Jemal, A., Thun, M.J., Ries, L.A., et al. Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control. J Natl Cancer Inst 100 (2008), 1672–1694.
15. Shafey, O., Eriksen, M., Ross, H., et al. The Tobacco Atlas, 3rd, 2009, American Cancer Society, Atlanta, GA.
16. Harris, J.E., Cigarette smoking among successive birth cohorts of men and women in the United States during 1900-80. J Natl Cancer Inst 71 (1983), 473–479.
17. Bray, F., Lortet-Tieulent, J., Ferlay, J., et al. Prostate cancer incidence and mortality trends in 37 European countries: an overview. Eur J Cancer 46 (2010), 3040–3052.
18. Andriole, G.L., Crawford, E.D., Grubb, R.L. 3rd, et al. Mortality results from a randomized prostate-cancer screening trial. N Engl J Med 360 (2009), 1310–1319.
19. Bertuccio, P., Chatenoud, L., Levi, F., et al. Recent patterns in gastric cancer: a global overview. Int J Cancer 125 (2009), 666–673.
20. Kawakami, E., Machado, R.S., Ogata, S.K., et al. Decrease in prevalence of Helicobacter pylori infection during a 10-year period in Brazilian children. Arq Gastroenterol 45 (2008), 147–151.
21. Lee, J.K., Inoue, M., Otani, T., et al. JPHC Study Group. Gastric cancer screening and subsequent risk of gastric cancer: a large scale population based cohort study, with a 13-year follow-up in Japan. Int J Cancer 118 (2006), 2315–2321.
22. Perz, J.F., Armstrong, G.L., Farrington, L.A., et al. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol 45 (2006), 529–538.
23. Shin, H.R., Oh, J.K., Masuyer, E., et al. Epidemiology of cholangiocarcinoma: an up- date focusing on risk factors. Cancer Sci 101 (2010), 579–585.
24. El-Serag, H.B., Epidemiology of hepatocellular carcinoma in USA. Hepatol Res 37:suppl 2 (2007), S88–S94.
25. Altekruse, S.F., McGlynn, K.A., Reichman, M.E., Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol 27 (2009), 1485–1491.
26. World Health Organization. Vaccine-Preventable Diseases: Monitoring System 2009 Global Summary. WHO/UNICEF Coverage Estimates for 1980-2008, as of August 2009. Available at: http://www.who.int/immunization_monitoring/routine/immunization_coverage/en/index4.html. Accessed January 5, 2010.
27. Centers for Disease Control and Prevention (CDC). Implementation of newborn hepatitis B vaccination–worldwide, 2006. MMWR Morb Mortal Wkly Rep 57 (2008), 1249–1252.
28. Ferlay, J., Shin, H.R., Bray, F., et al. GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10, 2010, International Agency for Research on Cancer; Year, Lyon, France Available at: http://globocan.iarc.fr. Last accessed 8/17/2010.
29. Parkin, D.M., Almonte, M., Bruni, L., et al., Clifford, G., Curado M, P., Pineros, M., Burden and trends of type-specific human papillomavirus infections and related diseases in the latin america and Caribbean region. Vaccine 26:suppl 11 (2008), L1–L15.
30. Villa LL, Costa RL, Petta CA, et al. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised doubleblind placebo-controlled multicentre phase II efficacy trial.
31. Gholipour, C., Shalchi, R.A., Abbasi, M., A histopathological study of esophageal cancer on the western side of the Caspian littoral from 1994 to 2003. Dis Esophagus 21 (2008), 322–327.
32. Tran, G.D., Sun, X.D., Abnet, C.C., et al. Prospective study of risk factors for esophageal and gastric cancers in the Linxian general population trial cohort in China. Int J Cancer 113 (2005), 456–463.
33. Islami, F., Boffetta, P., Ren, J.S., et al. High-temperature beverages and foods and esophageal cancer risk–a systematic review. Int J Cancer 125 (2009), 491–524.
34. Lee, C.H., Lee, J.M., Wu, D.C., et al. Independent and combined effects of alcohol intake, tobacco smoking and betel quid chewing on the risk of esophageal cancer in Taiwan. Int J Cancer 113 (2005), 475–482.
35. Phukan, R.K., Ali, M.S., Chetia, C.K., et al. Betel nut and tobacco chewing; potential risk factors of cancer of oesophagus in Assam, India. Br J Cancer 85 (2001), 661–667.
36. Karim-Kos, H.E., de Vries, E., Soerjomataram, I., et al. Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer 44 (2008), 1345–1389.
37. Felix, A.S., Soliman, A.S., Khaled, H., et al. The changing patterns of bladder cancer in Egypt over the past 26 years. Cancer Causes Control 19 (2008), 421–429.
38. Hartge, P., Wang, S.S., Bracci, P.M., et al. Non-Hodgkin lymphoma. Schottenfeld, D., J.F., Fraumeni Jr., (eds.) Cancer Epidemiology and Prevention, 2006, Oxford University Press, New York, 898–918.
39. Devesa, S.S., Fears, T., Non-Hodgkin's lym- phoma time trends: United States and international data. Cancer Res 52:19 suppl (1992), 5432s–5440s.
40. Blot, W.J., McLaughlin, J.K., Winn, D.M., et al. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res 48 (1988), 3282–3287.
41. Hashibe, M., Brennan, P., Chuang, S.C., et al. Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Cancer Epidemiol Biomarkers Prev 18 (2009), 541–550.
42. International Agency for Research on Cancer. Betal Quid and Areca Nut Chewing and Some Areca Nut Derived Nitrosamines. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, 85, 2004, IARC, Lyon, France.
43. International Agency for Research on Cancer. Smokeless Tobacco and Some Tobacco-Specific N-Nitrosamines. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, 89, 2007, IARC, Lyon, France.
44. Yu, M.C., Nasopharyngeal cancer. Schottenfeld, D., J.F., Fraumeni Jr., (eds.) Cancer Epidemiology and Prevention, 3rd, 2006, Oxford University Press, New York, 620–626.
45. Luo, J., Chia, K.S., Chia, S.E., et al. Secular trends of nasopharyngeal carcinoma incidence in Singapore, Hong Kong and Los Angeles Chinese populations, 1973-1997. Eur J Epidemiol 22 (2007), 513–521.
46. Hsu, C., Shen, Y.C., Cheng, C.C., et al. Difference in the incidence trend of nasopharyngeal and oro pharyngeal carcinomas in Taiwan: implication from age-period-cohort analysis. Cancer Epidemiol Biomarkers Prev 15 (2006), 856–861.
47. Sun, L.M., Epplein, M., Li, C.I., et al. Trends in the incidence rates of nasopharyngeal carcinoma among Chinese Americans living in Los Angeles County and the San Francisco metropolitan area, 1992-2002. Am J Epidemiol 162 (2005), 1174–1178.
48. Ministerio de Salud de Chile. Departamento de Estadísticas e Información en Salud. Indicadores Básicos de Salud Chile.2011.
49. Robles, S., White, F., Peruga, A., Tendencias de la mortalidad por cáncer de cuello de útero en las Américas. Bol Oficina Sanit Panam 121:6 (1996), 478–490.
50. Andia, M., Gederlini, A., Ferreccio, C., Cáncer de vesícula biliar: Tendencia y distribución del riesgo en Chile. Rev Méd Chile 134 (2006), 565–574.
51. Robles, S.C., Galanis, E., Breast cancer in Latin America and the Caribbean. Rev Panam Salud Publica 11:3 (2002), 178–185.
52. Vives, A., Valdivia, G., Marshall, G., Cambios recientes en la mortalidad por cáncer de próstata en Chile: estudio de tendencias en el período 1955-2001. Rev Méd Chile 132 (2004), 579–587.
53. Zarate, A.J., Alonso, F.T., Garmendia, M.L., et al. Increasing crude and adjusted mortality rates for colorectal cancer in a developing South American country. Colorectal Dis 15:1 (2013), 47–51.
54. MINSAL. Unidad De Vigilancia De Enfermedades No Trasmisibles y Estudios Departamento de Epidemiología. Primer Informe De Registros Poblacionales De Cáncer De Chile, Quinquenio, 2003-2007, Incidencia, Mortalidad y Estimación País, 1–178.